HRP940472A2 - Asymmetrically substituted diaminodicarboxylic acid derivatives and process for their preparation - Google Patents
Asymmetrically substituted diaminodicarboxylic acid derivatives and process for their preparation Download PDFInfo
- Publication number
- HRP940472A2 HRP940472A2 HRA1683/93A HRP940472A HRP940472A2 HR P940472 A2 HRP940472 A2 HR P940472A2 HR P940472 A HRP940472 A HR P940472A HR P940472 A2 HRP940472 A2 HR P940472A2
- Authority
- HR
- Croatia
- Prior art keywords
- residue
- mean
- image
- atoms
- phenyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 8
- 239000002253 acid Substances 0.000 title claims description 5
- 238000002360 preparation method Methods 0.000 title description 2
- -1 9-fluorenylmethyl Chemical group 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 13
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 229910052736 halogen Inorganic materials 0.000 claims description 9
- 238000005868 electrolysis reaction Methods 0.000 claims description 8
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 7
- 150000003862 amino acid derivatives Chemical class 0.000 claims description 6
- IVHKZGYFKJRXBD-UHFFFAOYSA-N amino carbamate Chemical class NOC(N)=O IVHKZGYFKJRXBD-UHFFFAOYSA-N 0.000 claims description 5
- 229910052697 platinum Inorganic materials 0.000 claims description 5
- 125000001424 substituent group Chemical group 0.000 claims description 5
- 238000006612 Kolbe reaction Methods 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- 125000004122 cyclic group Chemical group 0.000 claims description 3
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 30
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 26
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 3
- XAKBSHICSHRJCL-UHFFFAOYSA-N [CH2]C(=O)C1=CC=CC=C1 Chemical group [CH2]C(=O)C1=CC=CC=C1 XAKBSHICSHRJCL-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- PVFCXMDXBIEMQG-JTQLQIEISA-N (2s)-2-(phenylmethoxycarbonylamino)pentanedioic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 PVFCXMDXBIEMQG-JTQLQIEISA-N 0.000 description 1
- AQTUACKQXJNHFQ-LURJTMIESA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanedioic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CCC(O)=O AQTUACKQXJNHFQ-LURJTMIESA-N 0.000 description 1
- SCEJQXRUWDSIBB-UHFFFAOYSA-N 2,2-diaminooctanedioic acid Chemical class OC(=O)C(N)(N)CCCCCC(O)=O SCEJQXRUWDSIBB-UHFFFAOYSA-N 0.000 description 1
- DCERHCFNWRGHLK-UHFFFAOYSA-N C[Si](C)C Chemical compound C[Si](C)C DCERHCFNWRGHLK-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical group O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 125000006278 bromobenzyl group Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 125000004803 chlorobenzyl group Chemical group 0.000 description 1
- 125000002946 cyanobenzyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- QAVUAIFIABYJGI-UHFFFAOYSA-N diamino carbonate Chemical class NOC(=O)ON QAVUAIFIABYJGI-UHFFFAOYSA-N 0.000 description 1
- 125000006285 dibromobenzyl group Chemical group 0.000 description 1
- 150000001990 dicarboxylic acid derivatives Chemical class 0.000 description 1
- 125000006286 dichlorobenzyl group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical class [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006502 nitrobenzyl group Chemical group 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229920006395 saturated elastomer Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
- C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
- C07D207/448—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
- C07D207/452—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
- C25B3/00—Electrolytic production of organic compounds
- C25B3/20—Processes
- C25B3/29—Coupling reactions
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
Description
Izum se odnosi na nove asimetrično supstituirane derivate diaminokarbonske kiseline i postupak njihovog dobivanja. The invention relates to new asymmetrically substituted derivatives of diaminocarboxylic acid and the process for their preparation.
Asimetrično supstituirani derivati diaminodikarbonske kiseline su vrijedni međuproizvodi za sintezu peptida. Asymmetrically substituted diaminodicarboxylic acid derivatives are valuable intermediates for peptide synthesis.
U J. Org. Chem. 1980., 45, 3078-3080 opisani su asimetrično supstituirani derivati diaminosuberinske kiseline, koji se dobivaju miješanom KJolbe-sintezom. No, tamo nije uspjelo odvajanje simetričnih nusproizvoda. Nadalje je iz Tetrahedron Lett. 30, 1982, 33, 4724-4730 poznato dobivanje asimetrično supstituiranih derivata diaminopimelinske kiseline kompliciranom 9-stepenom enantioselektivnom sintezom. In J. Org. Chem. 1980, 45, 3078-3080 described asymmetrically substituted derivatives of diaminosuberic acid, which are obtained by mixed KJolbe synthesis. However, the separation of symmetrical by-products failed there. It is further from Tetrahedron Lett. 30, 1982, 33, 4724-4730 known to obtain asymmetrically substituted derivatives of diaminopimelic acid by a complicated 9-step enantioselective synthesis.
Na neočekivan način pronađeni su asimetrično supstituirani derivati diaminokarbonske kiseline, koji predstavljaju vrijedne međuproizvode za sintezu peptida i spojeve koji sadrže neprirodne aminokiseline. In an unexpected way, asymmetrically substituted derivatives of diaminocarbonic acid were found, which represent valuable intermediates for the synthesis of peptides and compounds containing unnatural amino acids.
Predmet izuma su stoga asimetrično supstituirani derivati diaminokarbonske kiseline The subject of the invention is therefore asymmetrically substituted diaminocarboxylic acid derivatives
[image] [image]
u kojoj A i B neovisno jedan od drugog znače ostatak -OR, pri čemu R znači eventualno jedno- ili višestruko halogenirani ravnolančani, razgranati ili ciklički alkilni ostatak sa 1-10 C-atoma, fenil ili ostatak -CH2-X, X znači ostatke 9-fluorofenil-, fenil-, -OCH3, -CH2SO2CH3, -CH2SO2C6H5, -CCl3, -CH2-Y, sa Y halogen, -p-tosil, eventualno jedno- ili višestruko halogen, -NO2 ili alkoksilom supstuirani ostatak fenila ili fenacila, difenilmetil, trifenilmetil, 2-piridil ili ostatak SiR1 R2 R3, pri čemu ostaci R1 R2 R3 neovisno jedan od drugoga znače ravnolančani ili razgranati alkilni ostatak sa 1-4 C-atoma ili fenil, in which A and B independently of each other mean the residue -OR, where R means an optionally mono- or multiply halogenated straight-chain, branched or cyclic alkyl residue with 1-10 C-atoms, phenyl or the residue -CH2-X, X means residues 9-fluorophenyl-, phenyl-, -OCH3, -CH2SO2CH3, -CH2SO2C6H5, -CCl3, -CH2-Y, with Y halogen, -p-tosyl, optionally mono- or multiple halogen, -NO2 or phenyl or phenacyl substituted by alkyl , diphenylmethyl, triphenylmethyl, 2-pyridyl or the residue SiR1 R2 R3, whereby the residues R1 R2 R3 independently of each other mean a straight-chain or branched alkyl residue with 1-4 C-atoms or phenyl,
E,F znače eventualno halogenirani ravnolančani, razgranati ili ciklički alkilni ostatak sa 1-10 C-atoma ili ostatak E, F mean a possibly halogenated straight-chain, branched or cyclic alkyl residue with 1-10 C-atoms or a residue
[image] [image]
pri čemu W 9-fluoremlmetil može značiti eventualno jedno- ili višestruko ili miješano halogenom, -NO2, alkoksilom ili -CN supstituirani benzilni ostatak ili supstituenti E odn. F, kod otpadanja atoma vodika, zajedno sa atomom dušika čine jedan od sljedećih prstenastih sistema where W 9-fluoroemlmethyl may mean possibly a single or multiple or mixed halogen, -NO2, alkyl or -CN substituted benzyl residue or substituents E or F, when the hydrogen atom is removed, together with the nitrogen atom they form one of the following ring systems
[image] [image]
pri čemu, ako su ostaci A i B različiti, E i F mogu biti različiti ili jednaki, a ako su ostaci A i B jednaki, E i F moraju biti različiti, a n znači cijeli broj od 2 do 10, pri čemu se središta kiraliteta u molekulama određuju korištenim eduktima, a oba L ili oba D ili D,L odn. L,D mogu biti konfigurirani. where, if the residues A and B are different, E and F can be different or the same, and if the residues A and B are the same, E and F must be different, and n means an integer from 2 to 10, where the centers of chirality in molecules are determined by the educts used, and both L or both D or D,L resp. L,D can be configured.
Daljnji predmet izume je postupak za dobivanje takvih asimetrično supstituiranih kerivata diaminokarbonske kiseline, miješanom Kolbe-sintezom, naznačeno time, da se zaštićeni derivat aminokiseline formule A further object of the invention is a process for obtaining such asymmetrically substituted derivatives of diaminocarboxylic acid, by mixed Kolbe synthesis, characterized by the fact that the protected amino acid derivative of the formula
[image] [image]
u kojoj A i E imaju gornje značenje, a k znači cijeli broj, sa derivatom aminokiseline formule in which A and E have the above meaning and k means an integer, with the amino acid derivative of the formula
[image] [image]
u kjoj B i F imaju gornje značenja, A 1 znači cijeli broj, pri čemu d i 1 zajedno daju broj n, podvrgne elektrolizi na platinskim mrežnim elektrodama. in which B and F have the above meanings, A 1 means an integer, where d and 1 together give the number n, subjected to electrolysis on platinum network electrodes.
U formulama I, II i III A i B znače ostatak -OR, pri čemu R znači eventualno jedno, ili višestruko halogeniram ravnolančani ili razgranati ili ciklički alkilni ostatak sa 1-10 C-atoma, primjerice eventualno halogenirani metilni, etilni, i-propilni, n-butilni, i-butilni, t-butilni ostatak i sl., cikloheksilni, ciklopentilni ili ciklobutilni ostatak ili fenil. In formulas I, II and III, A and B mean the residue -OR, where R means possibly one or more halogenated straight-chain or branched or cyclic alkyl residue with 1-10 C-atoms, for example optionally halogenated methyl, ethyl, i-propyl , n-butyl, i-butyl, t-butyl residue, etc., cyclohexyl, cyclopentyl or cyclobutyl residue or phenyl.
Nadalje R može značiti ostatak -CH2-X, pri čemu X znači ostatke 9-fluorofenila, fenila, -OCH3, -CH2SO2CH3, -CH2SO2C6H5, -CCl3, -CH2-Y, sa Y halogen, -p-tosil, eventualno jedno- ili višestruko halogenom –NO2 ili alkoksilom supstituirani fenilni ili fenacilni ostatak, primjerice p-bromfenacil, p-klorfenacil i sl., difenilmetil, trifenilmetil, 2-piridil ili ostatak –SiR1 R2 R3, pri čemu ostaci R1 R2 R3 neovisno jedan od drugoga znače ravnolančani ili razgranati alkilni ostatak sa 1-4 C-atoma ili fenil. Furthermore, R can mean the residue -CH2-X, where X means the residues of 9-fluorophenyl, phenyl, -OCH3, -CH2SO2CH3, -CH2SO2C6H5, -CCl3, -CH2-Y, with Y halogen, -p-tosyl, possibly one- or a phenyl or phenacyl radical substituted multiple times by halogen -NO2 or alkoxyl, for example p-bromophenacyl, p-chlorophenacyl, etc., diphenylmethyl, triphenylmethyl, 2-pyridyl or the residue -SiR1 R2 R3, where the residues R1 R2 R3 independently of each other mean straight-chain or branched alkyl radical with 1-4 carbon atoms or phenyl.
A i B uglavnom znače ostatak -OR, pri čemu R znači ostatak 9-fluorenilmetila, supstituirani ili nesupstituirani ostatak fenila, benzila, fenacila ili eventualno halogenirani ravnolančani ili razgranati alkilni ostatak sa 1-4 C-atoma. A and B mainly mean the residue -OR, where R means the residue 9-fluorenylmethyl, substituted or unsubstituted phenyl, benzyl, phenacyl or optionally halogenated straight-chain or branched alkyl residue with 1-4 C-atoms.
Ostaci E i F znače eventualno halogenirani ravnolančani, razgranati ili ciklički alkilni ostatak sa 1-10 C-atoma, primjerice ostatak metila, etila, n-propila, i-propila, n-butila, i-butila, t-butila, pentila, heksila i sl, koji eventulano jedno-ili višestruko može biti halogeniran. Residues E and F mean an optionally halogenated straight-chain, branched or cyclic alkyl residue with 1-10 C-atoms, for example a methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, pentyl, hexyl, etc., which may be halogenated one or more times.
Nadalje E i F mogu značiti ostatak Furthermore, E and F can mean the remainder
[image] [image]
pri čemu W znači ostatak 9-fluorenilmetila ili eventualno jedno- ili višestruko miješani halogenom, NO2, alkoksilom ili -CN supstituirani ostatak benzila, primjerice ostatak brombenzila, dibrombenzila, klorbenzila, diklorbenzila, nitrobenzila, metoskibenzila, cijanobenzila. where W means a 9-fluorenylmethyl residue or optionally a benzyl residue substituted with halogen, NO2, alkoxyl or -CN, for example, a bromobenzyl, dibromobenzyl, chlorobenzyl, dichlorobenzyl, nitrobenzyl, methoxybenzyl, cyanobenzyl residue.
Nadalje mogu supstituenti E odn. F kod otpadanja atoma vodika, činiti jedan od navedenih prstenastih sistema. Furthermore, the substituents E or F when a hydrogen atom falls off, to form one of the mentioned ring systems.
Ostaci E i F uglavnom znače ostatak The residues E and F generally mean the remainder
[image] [image]
pri čemu W znači ostatak 9-fluorenilmetila, eventualno supstituirani ostatak benzila ili ravnolančani ili razgranati ostatak alkila sa 1-4 C-atoma. where W means a 9-fluorenylmethyl residue, an optionally substituted benzyl residue or a straight-chain or branched alkyl residue with 1-4 C atoms.
Ako su ostaci A i B različiti, supstituenti na aminofunkciji dikarbonske kiseline mogu biti isti ili različiti. Ako su ostaci A i B isti, supstituenti na aminofunkciji dikarbonske kiseline moraju biti različiti. If residues A and B are different, the substituents on the amino function of the dicarboxylic acid can be the same or different. If residues A and B are the same, the substituents on the amino function of the dicarboxylic acid must be different.
Središta kiraliteta dikarbonske kiseline određuju se odabirom korištenih edukta. Oni mogu ili oba biti D ili oba L ili D,L, odn. L,D, primjerice mono-A-ester-mono-B-ester-N'-E-N"-F-2,7-D,L-2,7-diaminosubermske kiseline kod korištenja A-estera N-E-D-glutaminske kiseline i B-estera N-F-L-glutaminske kiseline mogu biti konfigurirani. The chirality centers of the dicarboxylic acid are determined by the selection of the educts used. They can either be D or both L or D,L, respectively. L,D, for example mono-A-ester-mono-B-ester-N'-E-N"-F-2,7-D,L-2,7-diaminosubermic acid when using A-ester N-E-D-glutamic acid and B -esters of N-F-L-glutamic acid can be configured.
Asimetrično supstituirani derivati dikarbonske kiseline prema izumu mogu se dobiti miješanom Kolbe-sintezom. Asymmetrically substituted dicarboxylic acid derivatives according to the invention can be obtained by mixed Kolbe synthesis.
Pri tome se odredjeni zastićeni derivati aminokiseline podvrgavaju elektrolizi na platinskim mrežnim elektrodama. In doing so, certain protected amino acid derivatives are subjected to electrolysis on platinum network electrodes.
Polazni spojevi poznati su u literaturi ili se mogu dobiti metodama koje su stručnjaku poznate. The starting compounds are known in the literature or can be obtained by methods known to the person skilled in the art.
Pri tome se derivati aminokiseline raastvore u otapalu pod reakcijskim uvjetima. In doing so, the amino acid derivatives are dissolved in the solvent under the reaction conditions.
Kao otapala u obzir dolaze primjerice niski alifatski alkoholi, primjerice metanol, etanol, propanol ili i-propanol ili heterocikličko otapalo kao primjerice piridin ili dimetilformamid, acetonitril, nitrometan ili mješavine takovih otapala. Suitable solvents are, for example, lower aliphatic alcohols, for example methanol, ethanol, propanol or i-propanol or a heterocyclic solvent such as pyridine or dimethylformamide, acetonitrile, nitromethane or mixtures of such solvents.
U elektrolitnoj ćeliji otopini se doda baza, primjerice alkalni metal u alkoholnoj otopini, kao natrijum metoksid u metanolu ili kalijum etoksid u etanolu. In the electrolytic cell, a base is added to the solution, for example an alkali metal in an alcoholic solution, such as sodium methoxide in methanol or potassium ethoxide in ethanol.
Na kraju se na platinskim mrežnim elektrodama uz hlađenje elektrolizira uz održavanje temperature na 18°-25°C. Jačina struje kod elektrolize iznosi oko 5-15 A kod napona od 60-120 V, a inače ovisi o geometriji korištene elektrode. At the end, it is electrolyzed on platinum network electrodes with cooling, maintaining the temperature at 18°-25°C. The current strength during electrolysis is about 5-15 A at a voltage of 60-120 V, and otherwise depends on the geometry of the electrode used.
Postupak elektrolize je završen, čim se u elektroliznoj otopini više ne može naći nikakav edukt. The electrolysis process is completed as soon as no educt can be found in the electrolysis solution.
Elektrolizna otopina se na kraju eventualno zgusne pod niskim pritiskom, ostatak se stavi u prikladno otapalo primjerice etilacetat i ta otopina se ispire prvo sa razrijeđenom kiselinom, primjerice razrijeđenom solnom kiselinom, zasićenom solnom otopinom, primjerice zasićenom otopinom natrijumhidrogenkarbonata i zasićenom otopinom natrijum klorida. At the end, the electrolysis solution is eventually thickened under low pressure, the residue is placed in a suitable solvent, for example ethyl acetate, and this solution is washed first with dilute acid, for example dilute hydrochloric acid, saturated salt solution, for example saturated sodium hydrogencarbonate solution and saturated sodium chloride solution.
Otopina se na kraju suši prikladnim sredstvom za sušenje, primjerice natrijum sulfatom ili magnezijum sulfatom, filtrira i ponovno zguzsnem, eventualno pod niskim pritiskom. Finally, the solution is dried with a suitable drying agent, for example sodium sulfate or magnesium sulfate, filtered and thickened again, possibly under low pressure.
Ostatak se kromatografski pročiščava, primjerice preko silika gela, pri čemu se simetrično substituirani nusproizvodi mogu odvojiti. Nakon reakcije dobiva se 10-15% teorije prema željenom asimetrično supstituiranom krajnjem proizvodu. The residue is chromatographically purified, for example over silica gel, whereby the symmetrically substituted by-products can be separated. After the reaction, 10-15% of theory is obtained according to the desired asymmetrically substituted end product.
Primjer 1 Example 1
29,41 g (96 mmol) a-t-butilestera N-t-butiloksikarbonilglutaminske kiseline i 35,63 g (96 mmol) a-benzilestera N-benziloksikarbonilglutaminske kiseline rastvori se mućkanjem u 240 MeOH i 80 ml piridina. Reakcijska otopina prenese se u elektrolitsku ćeliju sa cilindrično poredanim platinskim mrežnim elektrodama. Ispere se sa MeOH i elektrolitska ćelija napuni se toliko sa MeOH, da su obje elektrode potpuno uronjene. 29.41 g (96 mmol) of a-t-butyl ester of N-t-butyloxycarbonylglutamic acid and 35.63 g (96 mmol) of a-benzyl ester of N-benzyloxycarbonylglutamic acid were dissolved by shaking in 240 MeOH and 80 ml of pyridine. The reaction solution is transferred to an electrolytic cell with cylindrical platinum network electrodes. It is washed with MeOH and the electrolytic cell is filled with MeOH so much that both electrodes are completely immersed.
Sad se doda 0.8 ml NaOCH3 (30% u MeOH) i elektrolitska ćelija se dobro rashladi. Kad je reakcijska mješavina ohlađena na 15°C uključi se mrežni uređaj. Reguliranjem temperature, odn. reguliranjem jačine struje odn. napona struje (5-15 A, 60-120V), temperatura se održava između +18°C i 24°C. Now add 0.8 ml of NaOCH3 (30% in MeOH) and cool the electrolytic cell well. When the reaction mixture has cooled to 15°C, turn on the mains device. By regulating the temperature, or by regulating the current or current voltage (5-15 A, 60-120V), the temperature is maintained between +18°C and 24°C.
Tok reakcije kontrolira se pomoću DC-a. Nakon potpune reakcije reakcijska otopina se rotira kod 40°C. The reaction flow is controlled by DC. After the complete reaction, the reaction solution is rotated at 40°C.
Ostatak Kolbe-sinteze se rastvori u 500 ml etilacetata, ispere prvo sa razrijeđenom HCl-otopinom (25 ml HCl konc. sa H2O napunjeno do 250 ml), potom sa 250 ml NaHCO3 i na kraju sa po 250 ml NaCl do neutralnosti vodene faze. The Kolbe-synthesis residue is dissolved in 500 ml of ethyl acetate, washed first with a diluted HCl solution (25 ml of concentrated HCl with H2O filled to 250 ml), then with 250 ml of NaHCO3 and finally with 250 ml of NaCl until neutrality of the aqueous phase.
Organska faza se suši sa Na2SO4, filtrira i upari. Ostatak nakon uparavanja:58,17 g. The organic phase is dried with Na2SO4, filtered and evaporated. Remainder after pairing: 58.17 g.
Ostatak uparavanja filtrira se preko dijatomejske zemlje i na kraju podijeli pomoću HPLC. The residue of the evaporation is filtered through diatomaceous earth and finally separated by HPLC.
Dobivena količina: 4,5 g čistog mono-t-butilestera monobenzilestera N'-benziloksikarboml-N"-t- butiiloksi karbonil- 2,7-diaminosuberinske kiseline (10% teorije). Amount obtained: 4.5 g of pure mono-t-butyl ester of monobenzyl ester of N'-benzyloxycarboml-N"-t-butyloxycarbonyl-2,7-diaminosuberic acid (10% of theory).
Točka tečenja 51-56 C, (α)D=21,5°. Pour point 51-56 C, (α)D=21.5°.
Na analogan način dobivaju se sljedeći spojevi: The following compounds are obtained in an analogous way:
[image] [image]
Kod primjera 5 i 14 miješano su stavljeni odgovarajući D- i L- derivati aminokiseline. In examples 5 and 14, the corresponding D- and L-derivatives of the amino acid were mixed.
Kemijski podaci gore navedenih spojeva, pri čemu korištene skraćenice imaju sljedeća značenja: Chemical data of the above-mentioned compounds, where the abbreviations used have the following meanings:
Skraćenica Značenje Abbreviation Meaning
OBn O-benzil OBn O-benzyl
OMe O-metil OMe O-methyl
OEtTos O-etiltosil OEtTos O-ethyltosyl
OtBu O-tert-butil OtBu O-tert-butyl
Boc t-butiloksikarbonil Boc t-butyloxycarbonyl
Z benziloksikarbonil Z benzyloxycarbonyl
SUB n=4 SAT n=4
PIM n=3 PIM n=3
ADI n=2 ADI n=2
Primjer 1: Boc-Z-SUB-OtBu-OBn Example 1: Boc-Z-SUB-OtBu-OBn
13C(CDCl3 100MHz) : 24.80(CH2), 24.82(CH2), 28.02(0-t-Bu-CH3), 28,34(Boc-CH3), 32.52(CH2), 32.72(CH2), 53.82(CH), 67.00 i 67.12 (benzil-CH2), 79.62 ((CH3)3C od Boc), 81.57((CH3)3C od OtBu), 128.09 - 128.63 (aromatski-C), 135.36, 136.30, 155.34 i 155.87 (karbamat-CO), 171.86 i 172.22(CO). 13C(CDCl3 100MHz) : 24.80(CH2), 24.82(CH2), 28.02(0-t-Bu-CH3), 28.34(Boc-CH3), 32.52(CH2), 32.72(CH2), 53.82(CH) . ), 171.86 and 172.22(CO).
Točka tečenja 51°-56°C. Pour point 51°-56°C.
(α)D = 21.5 (α) D = 21.5
Primjer 2: Di-Bos-SUB-OBn-OMe Example 2: Di-Bos-SUB-OBn-OMe
13C(CDCl3, 100MHz) : 24.82(2CH2), 28.31 (2(CH3)3C), 32.49(CH2), 32.54(CH2), 52.18(OCH3), 53.38(br s, 2CH), 66.99(benzil-CH2), 128.31, 128,42, 128.59, 135.46', i 155.32 (2 karbamat-CO), 172.57 i 173.20 (ester-CO). 13C(CDCl3, 100MHz) : 24.82(2CH2), 28.31 (2(CH3)3C), 32.49(CH2), 32.54(CH2), 52.18(OCH3), 53.38(br s, 2CH), 66.99(benzyl-CH2) , 128.31, 128.42, 128.59, 135.46', and 155.32 (2 carbamate-CO), 172.57 and 173.20 (ester-CO).
Točka tečenja 55°-590°C Pour point 55°-590°C
(α)D=24.9 (1% u DMF) (α)D=24.9 (1% in DMF)
Primjer 3: Boc-Z-SUB-Di-OBn Example 3: Boc-Z-SUB-Di-OBn
13C(CDCl3, 100MHz) : 24.68(CH2), 24.81(CH2), 28.32(2 (CH3)3C), 32.74(2CH2), 53.37(CH), 53.88(CH), 66.99(benzil-CH2), 67.13(benzil-CH2), 79.90((CH3)3C), 128.10-128.63(aromatski-C), 135.33 135.46, 136.28, 155.30 i 155.83(karbamat-CO), 172.17 i 172.56(ester-CO) 13C(CDCl3, 100MHz) : 24.68(CH2), 24.81(CH2), 28.32(2(CH3)3C), 32.74(2CH2), 53.37(CH), 53.88(CH), 66.99(benzyl-CH2), 67.13( benzyl-CH2), 79.90((CH3)3C), 128.10-128.63(aromatic-C), 135.33 135.46, 136.28, 155.30 and 155.83(carbamate-CO), 172.17 and 172.56(ester-CO)
Točka tečenja 65° - 67°C Pour point 65° - 67°C
(α)D=1.4 (5% u CHCl3) (α)D=1.4 (5% in CHCl3)
Primjer 4: Boc-Z-SUB-OBn-OEtTos Example 4: Boc-Z-SUB-OBn-OEtTos
13C(CDCl3, 100MHz): 21.65(tolil-CH3), 24.65(CH2), 24.81(CH2), 28.32((CH3)3C), 32.06(CH2), 32.38(CH2), 53.12(CH), 53.80(CH), 54.94(OCH2CH2SO2C7H7), 58.27(OCH2CH2SO2C7H7), 67.01 (benzil-CH2), 67.17(benzil-CH2), 80.05((CH3)3C), 128.12-128.65(aromatski-C), 130.08, 135.32, 136.27, 145.23, 155.26 i 155.90 (karbamat-CO), 172.15 (2 ester-CO) 13C(CDCl3, 100MHz): 21.65(tolyl-CH3), 24.65(CH2), 24.81(CH2), 28.32((CH3)3C), 32.06(CH2), 32.38(CH2), 53.12(CH), 53.80(CH ), 54.94(OCH2CH2SO2C7H7), 58.27(OCH2CH2SO2C7H7), 67.01 (benzyl-CH2), 67.17(benzyl-CH2), 80.05((CH3)3C), 128.12-128.65(aromatic-C), 130.08, 135.32, 136.272, 145. , 155.26 and 155.90 (carbamate-CO), 172.15 (2 ester-CO)
Ulje Oil
(α)D=+3.45 (5% u CHCl3) (α)D=+3.45 (5% in CHCl3)
Primjer 5: Di-Boc-D,L-SUB-OBn-OEtTos Example 5: Di-Boc-D,L-SUB-OBn-OEtTos
13C(CDCl3, 100MHz): 21.63(tolil-CH3), 24.79(CH2), 24.84(CH2), 28.31(2(CH3)3C), 32.13(CH2), 32.52(CH2), 53.23(br s, 2CH), 54.99(OCH2CH2SO2C7H7), 58.28(OCH2CH2SO2C7H7), 67.01(benzil-CH2), 79.98(2(CH3)3C), 128.13-128.61(aromatski-C), 135.45, 136.35, 145.21, 155.30 i 155.83 (karbamat-CO), 172.11 (2 ester-CO) 13C(CDCl3, 100MHz): 21.63(tolyl-CH3), 24.79(CH2), 24.84(CH2), 28.31(2(CH3)3C), 32.13(CH2), 32.52(CH2), 53.23(br s, 2CH) . , 172.11 (2 ester-CO)
Primjer 6: Boc-Z-PIM-OBn-OEtTos Example 6: Boc-Z-PIM-OBn-OEtTos
13C(CDCl3, 100MHz): 21.10(CH2), 21.60(tolil-CH3), 28.31((CH3)3C), 31.62(CH2), 31.90(CH2), 52.85(CH), 53.55(CH), 54.93(OCH2CH2SO2C7H7), 58.32(OCH2CH2SO2C7H7), 67.05 i 67.22(benzil-CH2), 80.08 ((CH3), 128.11-128.66 (aromatski-C), 130.05, 135.31, 136.25, 145.21, 155.45 i 155.83 (karbamat-CO), 171.97 i 172.08(ester.CO). 13C(CDCl3, 100MHz): 21.10(CH2), 21.60(tolyl-CH3), 28.31((CH3)3C), 31.62(CH2), 31.90(CH2), 52.85(CH), 53.55(CH), 54.93(OCH2CH2SO2C7H7 ), 58.32(OCH2CH2SO2C7H7), 67.05 and 67.22(benzyl-CH2), 80.08 ((CH3), 128.11-128.66 (aromatic-C), 130.05, 135.31, 136.25, 145.21, 155.45 and 155.83 (carbamate-CO), 17.97 and 17.97 172.08(ester.CO).
Primjer 7: Boc-Z-ADI-OBn-OEtTos Example 7: Boc-Z-ADI-OBn-OEtTos
13C(CDCl3, 100MHz): 21.60(tolil-CH3), 28.17((CH3)3C), 28.29(CH2), 52.79(CH), 53.61(CH), 54.87(OCH2CH2SO2C7H7), 58.2(OCH2CH2SO2C7H7), 67.04 i 67.31(benzil-CH2), 80.18((CH3)3C), 128.05-128.67(aromatski-C), 130.09, 135.24, 136.20, 136.26, 145.27 i 156.00(2 karbamat-CO), 171.59 i 171.75(ester-CO) 13C(CDCl3, 100MHz): 21.60(tolyl-CH3), 28.17((CH3)3C), 28.29(CH2), 52.79(CH), 53.61(CH), 54.87(OCH2CH2SO2C7H7), 58.2(OCH2CH2SO2C7H7), 67.04 and 67.31 (benzyl-CH2), 80.18((CH3)3C), 128.05-128.67(aromatic-C), 130.09, 135.24, 136.20, 136.26, 145.27 and 156.00(2 carbamate-CO), 171.59 and 171.75(ester-CO)
Primjer 8: Boc-Z-PIM-OBn-OMe Example 8: Boc-Z-PIM-OBn-OMe
13C(CDCl3, 100MHz): 20.82(CH2), 21.16(CH2). 28.31((CH3)3C), 31.97(CH2), 32.17(CH2), 52.23(OMe), 52.93(CH), 53.61(CH), 67.07(benzil-CH2), 80.01 ((CH3)3C), 128.17-128.64(aromatski-C). 135.29, 136.23, 155.55 i 156.06(karbamat-CO), 172.12 i 173.06(ester-CO) 13C(CDCl3, 100MHz): 20.82(CH2), 21.16(CH2). 28.31((CH3)3C), 31.97(CH2), 32.17(CH2), 52.23(OMe), 52.93(CH), 53.61(CH), 67.07(benzyl-CH2), 80.01 ((CH3)3C), 128.17- 128.64 (aromatic-C). 135.29, 136.23, 155.55 and 156.06 (carbamate-CO), 172.12 and 173.06 (ester-CO)
Primjer 9: Boc-Z-PIM-OBn-OCH2COC6H5 Example 9: Boc-Z-PIM-OBn-OCH2COC6H5
13C(CDCl3, 100MHz): 20.82(2CH2), 28.33((CH3)3C, 31.86(CH2), 32.16(CH2), 53.08(CH), 53.69(CH), 66.35(OCH2COC6H5), 66.97(benzil-CH2), 67.13(benzil-CH2). 80.05((CH3)3C), 127.77 - 128.89(aromatski-C), 133.99, 135.43, 136.36, 155.51 i 156.17(karbamat-CO), 172.16(2 ester-CO), 191.61(OCH2COC6H5) 13C(CDCl3, 100MHz): 20.82(2CH2), 28.33((CH3)3C, 31.86(CH2), 32.16(CH2), 53.08(CH), 53.69(CH), 66.35(OCH2COC6H5), 66.97(benzyl-CH2) , 67.13(benzyl-CH2). 80.05((CH3)3C), 127.77 - 128.89(aromatic-C), 133.99, 135.43, 136.36, 155.51 and 156.17(carbamate-CO), 172.16(2 ester-CO), 191.61( OCH2COC6H5)
Primjer 10: Boc-Z-PIM-OBn-OCH2CH2Si(CH3)3 Example 10: Boc-Z-PIM-OBn-OCH2CH2Si(CH3)3
13C(d6-DMSO, 100 MHz): -1.54(CH3)3Si), 17.42(OCH2CH2Si(CH3)3), 21.22(CH2), 22.20(CH2), 28.32((CH3)3C), 31.91(CH2), 32.34(CH2), 53.01(CH), 53.73(CH), 63.74(OCH2CH2Si(CH3)3), 67.05(benzil-CH2), 67.17(benzil-CH2), 79.89((CH3)3)C), 128.14, 128.26, 128.50, 128.64, 135.32, 136.25, 155.58 i 156.06(karbamat-CO), 172.17 i 172.68(2 ester-CO). 13C(d6-DMSO, 100 MHz): -1.54(CH3)3Si), 17.42(OCH2CH2Si(CH3)3), 21.22(CH2), 22.20(CH2), 28.32((CH3)3C), 31.91(CH2), 32.34(CH2), 53.01(CH), 53.73(CH), 63.74(OCH2CH2Si(CH3)3), 67.05(benzyl-CH2), 67.17(benzyl-CH2), 79.89((CH3)3)C), 128.14, 128.26, 128.50, 128.64, 135.32, 136.25, 155.58 and 156.06(carbamate-CO), 172.17 and 172.68(2 ester-CO).
Primjer 11: Boc-Z-PIM-Di-OBn Example 11: Boc-Z-PIM-Di-OBn
13C(CDCl3, 100MHz): 21.14(CH2), 28.20((CH3)3C), 31.92(CH2), 32.16(CH2), 53.07(CH). 53.64(CH), 67.06(2 benzil-CH2), 67.18(benzil-CH2), 79.98((CH3)3C), 128.16, 128.29, 128.44, 128.50, 128.61, 128.63, 135.30, 135.40, 136.24, 155.53 i 156.04(karbamat-CO), 172.09 i 172.41(2 ester-CO). 13C(CDCl3, 100MHz): 21.14(CH2), 28.20((CH3)3C), 31.92(CH2), 32.16(CH2), 53.07(CH). 53.64(CH), 67.06(2 benzyl-CH2), 67.18(benzyl-CH2), 79.98((CH3)3C), 128.16, 128.29, 128.44, 128.50, 128.61, 128.63, 135.30, 135.40, 136.25, 156.3 and 156.0( carbamate-CO), 172.09 and 172.41(2 ester-CO).
Primjer 12: Boc-Z-ADI-OBn-OCH2CCl3 Example 12: Boc-Z-ADI-OBn-OCH2CCl3
13C(CDCl3, 100MHz): 28.60((CH3)3C), 29.25(CH2), 30.00(CH2), 30.00(CH2), 53.34(CH), 53.78(CH), 74.67(OCH2CCl3, 67.72(benzil-CH2), 74.67(OCH2CCl3), 80.69((CH3)3C), 94.79(OCH2CCl3), 128.42, 128.54, 128.74, 128.87, 128.96, 129.02, 135.43, 136.46, 155.53 i 156.17(karbamat-CO), 171.09 i 171.96(2 CO). 13C(CDCl3, 100MHz): 28.60((CH3)3C), 29.25(CH2), 30.00(CH2), 30.00(CH2), 53.34(CH), 53.78(CH), 74.67(OCH2CCl3, 67.72(benzyl-CH2) . ).
Primjer 13: Boc-Z-ADI-Di-OBn Example 13: Boc-Z-ADI-Di-OBn
13C(CDCl3, 100MHz): 21.22(CH2), 22.20(CH2), 28.32((CH3)3C), 31.91(CH2), 32.34(CH2), 53.01(CH), 53.73(CH), 63.74(OCH2CH2Si(CH3)3), 67.05(benzil-CH2), 79.89((CH3)3C), 128.14, 128.26, 128.50, 128,64, 135.32, 136.25, 155.58 i 156.06(karbamat-CO), 172.17 i 172.68(2 ester-CO). 13C(CDCl3, 100MHz): 21.22(CH2), 22.20(CH2), 28.32((CH3)3C), 31.91(CH2), 32.34(CH2), 53.01(CH), 53.73(CH), 63.74(OCH2CH2Si(CH3) )3), 67.05(benzyl-CH2), 79.89((CH3)3C), 128.14, 128.26, 128.50, 128.64, 135.32, 136.25, 155.58 and 156.06(carbamate-CO), 172.17 and 172.68(2 ester-CO ).
Primjer 14: Boc-Z-D,L-PIM-OBn-OEtTos Example 14: Boc-Z-D,L-PIM-OBn-OEtTos
13C(CDCl3, 100MHz): 20.98(CH2), 21.58(tolil-CH3), 28.29((CH3)3C), 31.77(CH2), 31.93(CH2), 52.98(CH), 53.73(CH), 54.94(OCH2CH2SO2C7H7), 58.25(OCH2CH2SO2C7H7), 67.00 i 67.15(benzil-CH2), 80.10((CH3)3C), 128.09 -128.64(aromatski-C), 130.05, 135.31, 136.32, 145.19, 155.28 i 156.02(karbamat-CO), 171.87 i 171.94(ester-CO). 13C(CDCl3, 100MHz): 20.98(CH2), 21.58(tolyl-CH3), 28.29((CH3)3C), 31.77(CH2), 31.93(CH2), 52.98(CH), 53.73(CH), 54.94(OCH2CH2SO2C7H7 ), 58.25(OCH2CH2SO2C7H7), 67.00 and 67.15(benzyl-CH2), 80.10((CH3)3C), 128.09 -128.64(aromatic-C), 130.05, 135.31, 136.32, 145.19, 155.28 and 156.02), (carbamate-CO 171.87 and 171.94 (ester-CO).
Claims (4)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0168393A AT401517B (en) | 1993-08-20 | 1993-08-20 | ASYMMETRICALLY SUBSTITUTED DIAMINODICARBOXYLIC DERIVATIVES AND A METHOD FOR THE PRODUCTION THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP940472A2 true HRP940472A2 (en) | 1997-04-30 |
Family
ID=3518736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRA1683/93A HRP940472A2 (en) | 1993-08-20 | 1994-08-19 | Asymmetrically substituted diaminodicarboxylic acid derivatives and process for their preparation |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0639560A1 (en) |
JP (1) | JPH07173118A (en) |
CN (1) | CN1107463A (en) |
AT (1) | AT401517B (en) |
AU (1) | AU692774B2 (en) |
CA (1) | CA2127938A1 (en) |
CZ (1) | CZ199894A3 (en) |
FI (1) | FI943811A (en) |
HR (1) | HRP940472A2 (en) |
HU (1) | HUT68091A (en) |
IL (1) | IL110706A (en) |
NO (1) | NO304941B1 (en) |
NZ (1) | NZ264002A (en) |
RU (1) | RU2142450C1 (en) |
SK (1) | SK98594A3 (en) |
YU (1) | YU51494A (en) |
ZA (1) | ZA946323B (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4161521A (en) * | 1975-08-08 | 1979-07-17 | Merck & Co., Inc. | Somatostatin analogs |
GR77929B (en) * | 1981-01-29 | 1984-09-25 | Fujisawa Pharmaceutical Co | |
JPS6327499A (en) * | 1986-07-21 | 1988-02-05 | Asahi Chem Ind Co Ltd | Alpha,alpha'-diaminosuberic acid derivative |
-
1993
- 1993-08-20 AT AT0168393A patent/AT401517B/en not_active IP Right Cessation
-
1994
- 1994-07-13 CA CA002127938A patent/CA2127938A1/en not_active Abandoned
- 1994-07-14 NZ NZ264002A patent/NZ264002A/en unknown
- 1994-08-04 EP EP94112178A patent/EP0639560A1/en not_active Withdrawn
- 1994-08-05 AU AU68927/94A patent/AU692774B2/en not_active Ceased
- 1994-08-16 YU YU51494A patent/YU51494A/en unknown
- 1994-08-18 IL IL11070694A patent/IL110706A/en not_active IP Right Cessation
- 1994-08-18 SK SK985-94A patent/SK98594A3/en unknown
- 1994-08-19 HR HRA1683/93A patent/HRP940472A2/en not_active Application Discontinuation
- 1994-08-19 ZA ZA946323A patent/ZA946323B/en unknown
- 1994-08-19 CZ CZ941998A patent/CZ199894A3/en unknown
- 1994-08-19 FI FI943811A patent/FI943811A/en unknown
- 1994-08-19 JP JP6195542A patent/JPH07173118A/en not_active Withdrawn
- 1994-08-19 HU HU9402413A patent/HUT68091A/en active IP Right Revival
- 1994-08-19 NO NO943062A patent/NO304941B1/en not_active IP Right Cessation
- 1994-08-19 RU RU94030731A patent/RU2142450C1/en active
- 1994-08-20 CN CN94116814A patent/CN1107463A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1107463A (en) | 1995-08-30 |
FI943811A (en) | 1995-02-21 |
CA2127938A1 (en) | 1995-02-21 |
AT401517B (en) | 1996-09-25 |
CZ199894A3 (en) | 1995-03-15 |
AU692774B2 (en) | 1998-06-18 |
ATA168393A (en) | 1996-02-15 |
NO943062D0 (en) | 1994-08-19 |
HU9402413D0 (en) | 1994-11-28 |
IL110706A0 (en) | 1994-11-11 |
AU6892794A (en) | 1995-03-02 |
SK98594A3 (en) | 1995-07-11 |
NO943062L (en) | 1995-02-21 |
EP0639560A1 (en) | 1995-02-22 |
RU94030731A (en) | 1996-08-20 |
RU2142450C1 (en) | 1999-12-10 |
FI943811A0 (en) | 1994-08-19 |
JPH07173118A (en) | 1995-07-11 |
ZA946323B (en) | 1995-03-23 |
NZ264002A (en) | 1995-08-28 |
YU51494A (en) | 1997-09-30 |
NO304941B1 (en) | 1999-03-08 |
IL110706A (en) | 1999-11-30 |
HUT68091A (en) | 1995-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nutt et al. | Useful intermediates for synthesis of dicarba analogs of cystine peptides: selectively protected. alpha.-aminosuberic acid and. alpha.,. alpha.'-diaminosuberic acid of defined stereochemistry | |
EP3280721B1 (en) | Process for preparation of nitrogen mustard derivatives | |
Papadopoulos et al. | Anodic oxidation of N-acyl and N-alkoxycarbonyl dipeptide esters as a key step for the formation of chiral heterocyclic synthetic building blocks | |
NZ540722A (en) | Process for the preparation of pyrimidine compounds and intermediates thereof | |
US11708336B2 (en) | Anodic oxidation of 5-aminouracil | |
CN114105984A (en) | Preparation method of indolizine corrosion inhibitor | |
HRP940472A2 (en) | Asymmetrically substituted diaminodicarboxylic acid derivatives and process for their preparation | |
Kardassis et al. | Electrogenerated chiral cationic glycine equivalents—Part 2: Chiral 3-methoxy-2, 5-morpholinediones from (S)-α-hydroxy acids and dimethyl aminomalonate | |
Shono et al. | A new electroreductive annellation useful in synthesis of alkaloids | |
US5643438A (en) | Process for the preparation of substituted diamino-dicarboxylic acid derivatives | |
US5627302A (en) | Asymmetrically substituted diaminodicarboxylic acid derivatives | |
DK0968189T3 (en) | Process for Preparation of Nicotinic Acids | |
Zhang et al. | Synthesis and Biological Evaluation of Novel Anthranilic Diamides Containing N-H/CH 3-1 H-Pyrazole | |
WO2016201203A1 (en) | Processes for making ponatinib and intermediates thereof | |
JP2517606B2 (en) | (Z) -2-Cyano-2-oxymino-acetyl chloride | |
US6177520B1 (en) | Organic compounds | |
Eguchi et al. | Studies on Hypotensive Agents. Synthesis of 1-Substituted 3-(2-Chlorophenyl)-6-ethoxycarbonyl-5, 7-dimethyl-2, 4 (1H, 3H)-quinazolinediones | |
Brine et al. | Synthesis of 4, 4‐disubstituted piperidine analogs of (±)‐cis‐N‐[1‐(2‐hydroxy‐2‐phenylethyl)‐3‐methyl‐4‐piperidyl]‐N‐phenylpropanamide | |
JPH03284662A (en) | Alpha-monofluorosulfide and production thereof | |
Takamizawa et al. | Studies on Pyrimidine Derivatives and Related Compounds. LXXVII. Reaction of Thiamine Analogues with Diethyl Benzoylphosphonate | |
DE4334873A1 (en) | Asymmetrically substituted diaminodicarboxylic acid derivatives and process for their preparation | |
HORI et al. | Studies on Antitumor-active 2, 3-Dioxopiperazine Derivatives. II. Synthesis and Structure-Antitumor Activity Relationship of 1-Benzyl-2, 3-dioxopiperazine Derivatives | |
JPH02240051A (en) | Monotrifluoromethyl compound and production thereof | |
JPH03158489A (en) | Production of oxathiazine derivative | |
JPH0144711B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
ODBI | Application refused |